✦ LIBER ✦

5.9 Bendamustine and Alemtuzumab Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia: Interim Report of the Italian Trial

✍ Scribed by A. Tedeschi; M. Coscia; D. Rossi; F. Ricci; G. D'arena; E. Orlandi; V. Belsito Petrizzi; L. Scarfò; C. Vitale; E. Vismara; G. Gaidano; E. Morra; M. Massaia; M. Montillo

Book ID: 119218955
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 89 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.163

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5.10 Combination of Bendamustine and Ofa

5.10 Combination of Bendamustine and Ofatumumab (Bendofa) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Preliminary Report

✍ Agostino Cortelezzi; Anna Marina Liberati; Giuseppe Gritti; Antonio Cuneo; Gianl 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 104 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

An Italian retrospective study on the ro

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

✍ Agostino Cortelezzi; Giuseppe Gritti; Luca Laurenti; Antonio Cuneo; Stefania Cio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

5.23 Phase 2 Study of Navitoclax (ABT-26

5.23 Phase 2 Study of Navitoclax (ABT-263) Safety and Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Interim Results

✍ John F. Seymour; Andrew W. Roberts; Dennis A. Carney; Martin J.S. Dyer; Thomas J 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 71 KB

Bendamustine with or without rituximab i

Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study

✍ Emilio Iannitto; Fortunato Morabito; Salvatrice Mancuso; Massimo Gentile; Antone 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Subcutaneous Alemtuzumab in Fludarabine-

Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group

✍ Stilgenbauer, S.; Zenz, T.; Winkler, D.; Buhler, A.; Schlenk, R. F.; Groner, S.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 170 KB